Sign Up Today and Learn More About AIMEDBIO Stock
Invest in or calculate the value of your shares in AIMEDBIO or other pre-IPO companies through EquityZen's platform.
AIMEDBIO Stock
AIMEDBIO provides therapeutic solutions to patients with serious brain diseases.
About AIMEDBIO Stock
Founded
2018
Industries
Blockchain and Crypto, Internet Services, Commerce and Shopping
AIMEDBIO Press Mentions
Stay in the know about the latest news on AIMEDBIO
Top biotech deals in October 2025
labiotech • Nov 08, 2025
5 SMID-Cap Pharmas Poised for M&A Action
biospace • Oct 31, 2025
Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP
fiercepharma • Oct 20, 2025
Boehringer Ingelheim digs in on ADCs, offering up to $991M to license cancer prospect from Korea's AimedBio
fiercebiotech • Oct 17, 2025
Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal
biospace • Oct 15, 2025
Join now and verify your accreditation status to gain access to:
- AIMEDBIO Current Valuation
- AIMEDBIO Stock Price
- AIMEDBIO Management
- Available deals in AIMEDBIO and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- AIMEDBIO Cap Table and Funding History by Share Class and Liquidity Preferences
- AIMEDBIO Revenue and Financials
- AIMEDBIO Highlights
- AIMEDBIO Business Model
- AIMEDBIO Risk Factors
- AIMEDBIO Research Report from SACRA Research
Trading AIMEDBIO Stock
How to invest in AIMEDBIO stock?
Accredited investors can buy pre-IPO stock in companies like AIMEDBIO through EquityZen funds. These investments are made available by existing AIMEDBIO shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell AIMEDBIO stock?
Shareholders can sell their AIMEDBIO stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."